Gardasil, the HPV (Human Papillomavirus) vaccine on the Centers for Disease Control and Prevention’s (CDC) list of recommended inoculations for teenagers, has been the subject of debate worldwide since it was fast-tracked for approval in the US in 2006. The Merck-manufactured drug was developed to prevent infections caused by HPV, which is a group of 150 related viruses -- 15 of which are linked to cervical cancer. At the heart of the controversies are questions around the need for the vaccine, the efficacy of the vaccine and the fast-growing number of reports of severe reactions to the vaccine. The latter question has moved to the forefront of the debate as safety testing concerns have been raised and the number of vaccine-injured children has grown.
The Children’s Medical Safety Research Institute (CMSRI) is a medical and scientific collaborative established to provide research funding for independent studies on causal factors underlying the chronic disease and disability epidemic.